Aclaris Therapeutics
ACRS
ACRS
102 hedge funds and large institutions have $703M invested in Aclaris Therapeutics in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 22 closing their positions.
Holders
102
Holders Change
-2
Holders Change %
-1.92%
% of All Funds
2.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
39
Reduced
33
Closed
22
Calls
$20K
Puts
$1.49M
Net Calls
-$1.47M
Net Calls Change
-$5.35M
Top Buyers
| 1 |
1
D.E. Shaw & Co
New York
|
$25.2M |
| 2 |
DM
2
Deerfield Management
New York
|
$55.1M |
| 3 |
3
Franklin Resources
San Mateo,
California
|
$64M |
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
|
$65.8M |
| 5 |
5
BlackRock
New York
|
$54.1M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
HT
127
HAP Trading
New York
| – | – | – | – |
|